XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.1
Segment Reporting (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Net sales $ 676,844 $ 700,062  
Operating Income (Loss) 61,913 146,408  
Net Assets, Segment 13,667,414   $ 13,501,666
Life Science [Member]      
Segment Reporting Information [Line Items]      
Net sales 323,600 347,200  
Operating Income (Loss) 35,700 89,600  
Clinical Diagnostics [Member]      
Segment Reporting Information [Line Items]      
Net sales 352,100 351,800  
Operating Income (Loss) 26,300 57,100  
Other Segments [Member]      
Segment Reporting Information [Line Items]      
Net sales 1,100 1,100  
Operating Income (Loss) $ (100) $ (300)